Biosynth Welcomes Marie Leblanc as Executive Vice President of Life Sciences

Staad, 4 March 2025 - Biosynth are pleased to announce the appointment of Marie Leblanc to the role of Executive Vice President of Life Sciences.

Marie joins Biosynth from Lonza, bringing close to 20 years of experience in commercial leadership positions across various modalities in the CDMO market and in life science products. Through her career at Lonza, Marie’s engagement and leadership have been instrumental in shaping Lonza commercial success fostering best practice sharing and collaboration. Most recently, she was the Global Head of Account Management for Lonza Cell & Gene Technologies, and prior to this role, she was the Head of Sales EMEA for Lonza Small Molecules division.